D-Index & Metrics Best Publications

Evan D. Kharasch

Duke University
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 80 Citations 19,114 364 World Ranking 12067 National Ranking 6294

Research.com Recognitions

Awards & Achievements

2013 - Member of the National Academy of Medicine (NAM)

Overview

What is he best known for?

The fields of study Evan D. Kharasch is best known for:

Opioid
Morphine
CYP2D6

Evan D. Kharasch regularly links together related areas like Metoprolol in his Internal medicine studies. He frequently studies issues relating to Internal medicine and Metoprolol. He connects Pharmacokinetics with Dosing in his research. His work often combines Dosing and Pharmacokinetics studies. Evan D. Kharasch regularly ties together related areas like Nasal spray in his Pharmacology studies. Evan D. Kharasch performs multidisciplinary studies into Nasal spray and Nasal administration in his work. Evan D. Kharasch performs multidisciplinary study on Nasal administration and Route of administration in his works. He performs multidisciplinary study in the fields of Route of administration and Onset of action via his papers. In his research, Evan D. Kharasch undertakes multidisciplinary study on Onset of action and Oxycodone.

His most cited work include:

Nasal administration of opioids for pain management in adults (251 citations)
Gender differences in drug effects: implications for anesthesiologists (189 citations)
A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics (89 citations)

What are the main themes of his work throughout his whole career to date

Evan D. Kharasch performs integrative study on Internal medicine and Endocrinology. He incorporates Endocrinology and Internal medicine in his research. He undertakes interdisciplinary study in the fields of Pharmacology and Clinical pharmacology through his research. He performs integrative study on Biochemistry and Biophysics. In his work, he performs multidisciplinary research in Anesthesia and Anesthetic. His work often combines Anesthetic and Anesthesia studies. In his work, Evan D. Kharasch performs multidisciplinary research in Pharmacokinetics and Pharmacodynamics. He performs integrative Pharmacodynamics and Pharmacokinetics research in his work. His research ties Opioid and Receptor together.

Evan D. Kharasch most often published in these fields:

Internal medicine (76.47%)
Pharmacology (70.59%)
Biochemistry (52.94%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

K R Crews;A Gaedigk;A Gaedigk;H M Dunnenberger;J S Leeder;J S Leeder.
Clinical Pharmacology & Therapeutics (2014)

623 Citations

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites

Bojan Lalovic;Bojan Lalovic;Bojan Lalovic;Evan Kharasch;Evan Kharasch;Evan Kharasch;Christine Hoffer;Christine Hoffer;Christine Hoffer;Linda Risler;Linda Risler;Linda Risler.
Clinical Pharmacology & Therapeutics (2006)

505 Citations

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

J. K. Hicks;J. J. Swen;C. F. Thorn;K. Sangkuhl.
Clinical Pharmacology & Therapeutics (2013)

477 Citations

Psychedelic Effects of Ketamine in Healthy Volunteers Relationship to Steady-state Plasma Concentrations

Andrew T. Bowdle;Allen D. Radant;Deborah S. Cowley;Evan D. Kharasch.
Anesthesiology (1998)

424 Citations

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

J K Hicks;K Sangkuhl;J J Swen;V L Ellingrod.
Clinical Pharmacology & Therapeutics (2017)

424 Citations

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

K R Crews;A Gaedigk;H M Dunnenberger;T E Klein.
Clinical Pharmacology & Therapeutics (2012)

408 Citations

Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation.

Peter T. Manyike;Evan D. Kharasch;Thomas F. Kalhorn;John T. Slattery.
Clinical Pharmacology & Therapeutics (2000)

405 Citations

Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane

Evan D. Kharasch;Kenneth E. Thummel.
Anesthesiology (1993)

398 Citations

Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3

Kenneth E. Thummel;Cynthia Brimer;Kazuto Yasuda;Jaideep Thottassery.
Molecular Pharmacology (2001)

383 Citations

Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.

Rita B. Labroo;Mary F. Paine;Kenneth E. Thummel;Evan D. Kharasch.
Drug Metabolism and Disposition (1997)

338 Citations

If you think any of the details on this page are incorrect, let us know.